Crism Therapeutics Corporation Ord Npv (CRTX)

Sector:

Investment Firms

Index:

FTSE AIM All-Share

18.00p
   
  • Change Today:
    -1.50p
  • 52 Week High: 19.50
  • 52 Week Low: 17.00
  • Currency: UK Pounds
  • Shares Issued: 32.68m
  • Volume: 99,080
  • Market Cap: £5.88m

CRTX Overview

Founded in March 2016, CRISM Therapeutics employs an interdisciplinary team of pharmaceutical specialists based in Birmingham. We serve a wide range of international clients, aiming to improve the clinical performance of active pharmaceutical ingredients (APIs) via local drug delivery and personalised medicines.

Key Personnel

CEO: Andrew James Webb
Chief Scientific Officer: Christopher McConville
Independent Non-Executive Director: Gerald Beaney
Non-Executive Chairman: Nermeen Yunus Varawalla
Non-Executive Dir:

Contact Details

Address: Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands, USA,
Phone: +1 (925) 408 4621
Website: http://www.crismtherapeutics.com/

Listings

Sector: Investment Firms(LSE)
Index: FTSE AIM All-Share
ISIN: VGG042401262

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CRTX Market Data

Currency UK Pounds
Share Price 18.00p
Change Today -1.50p
% Change -7.69 %
52 Week High 19.50
52 Week Low 17.00
Volume 99,080
Shares Issued 32.68m
Market Cap £5.88m

CRTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Value Not Available
Income Not Available
Growth Not Available

CRTX Dividends

  Latest Previous
  Special Interim
Ex-Div 01-Jun-23 n/a
Paid 14-Jun-23 n/a
Amount 1.80p 0.000¢

Trades for 19-May-2025

Time Volume / Share Price
16:25 4 @ 19.00p
16:13 26 @ 17.00p
15:41 1,000 @ 17.36p
15:32 30 @ 17.52p
14:18 531 @ 17.52p

CRTX Key Personnel

CEO Andrew James Webb

Top of Page